RE: Hopefully12 Aug 2020 17:05
Yes, we need to add N4P to the list of pharma stocks that are rocketing and hopefully paving the way for Sareum next.
N4P up from 2p to 16p in 6 months. Note to Tim, John and Stephen: N4P have behaved just like the other pharma shares that have soared, wetting the appetite of investors over a few months with several RNS announcements. e.g. one of which said the ceo was going to spend more time on collaborations. The inference was clear and it is this subtle messaging that Sareum need to take on board. Another RNS announced 10 weeks ago what they were up to and the SP started to move this week in anticipation ahead of the expected news which has now been announced. N4P played the regulatory PR well (& it is only stage 2 currently). I am pointing this out - again - as this is yet another illustration of managing the share price up (not ramping). Hopefully, Sareum will be the next pharma stock to soar and do a ODX up x 13 in 6 months, a AVCT up x 15 in 6 months, a HEMO up x 15 in 6 months, a SNG up x 40 in 6 months, a NCYT up x 75 in 6 months, a PYC up x 11 in 6 months. Good luck, Brighty